100
Participants
Start Date
April 1, 2023
Primary Completion Date
December 1, 2024
Study Completion Date
December 31, 2024
Anamorelin Hydrochloride
Anamorelin HCl is an orally-active selective ghrelin receptor agonist which has shown anabolic and appetite-stimulating effects.
Placebo
Anamorelin placebo
RECRUITING
Lahey Hospital & Medical Center, Burlington
Lead Sponsor
Collaborators (1)
Helsinn Healthcare SA
INDUSTRY
Quartesian LLC
UNKNOWN
Lahey Clinic
OTHER